Hofseth BioCare ASA: Cancellation of Subsequent Offering – Update on completion of Private Placement

Core Viewpoint - Hofseth BioCare ASA has decided to cancel its Subsequent Offering due to delays in the completion of a Private Placement and current share price levels, resulting in refunds for subscribers [4]. Group 1: Subsequent Offering - The Company planned a Subsequent Offering with gross proceeds of up to approximately NOK 30,000,000 through the issuance of up to 16,666,666 new ordinary shares at a subscription price of NOK 1.80 per share [2]. - The Board of Directors has resolved to cancel the Subsequent Offering, and all subscription amounts for Offer Shares will be refunded to the subscribers [4]. - Subscribers wishing to maintain their subscription must contact the Company by 16.30 (CET) on 18 December 2025, or their subscription will be cancelled [4]. Group 2: Private Placement - The Company is awaiting the receipt of all share deposits related to the Private Placement, which is expected to be completed shortly [3]. - The Private Placement has already generated gross proceeds of approximately NOK 158 million [2].